Abstract
Urothelial Carcinoma is defined as the abnormal division of cells within the layers of tissue or urothelium of the renal pelvis, bladder, ureters, and the urethra. Cancer of the bladder, ureters, and urethra most commonly are missed diagnosed as urinary tract infections or nephrolithiasis. Patients may be given multiple courses of antibiotics and/or pain medication without resolution of their symptoms. Diagnosis and management of the disease is delayed, with risk of disease progression. This chapter presents the key point to evaluation and management of patients that present with known or suspected urothelial carcinoma, including identification of risk factors, diagnostic pathways, and guidelines for referral for surgical management.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Advanced Bladder Cancer Meta-analysis Collaboration (2003) Neoadjuvant chemotherapy in invasive bladder cancer: a systemic review and meta-analysis. Lancet 361(9373):1927–1934
Azemar MD, Comperat E, Richard F, Cussenot O, Roupret M (2011) Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma; frequency, risk factors, and surveillance. Urol Oncol 29(2):130–136
BCG Shortage Information (2019) American Urological Association. https://www.auanet.org/about-us/bcg-shortage-info
Cancer Statistics (2019) American Cancer Society. https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21551. Accessed 23 Jan 2020
Cookson MS, Chang SS, Lihou C, Li T, Harper SQ, Lang Z, Tutrone RF (2014) Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladder. Ther Adv Urol 6(5):181–191
Grossman HB, Natale RB, Tangen CM (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349(9):859–866. [Medline]
Guidos J, Powell C, Donohoe J, et al (2018) Urethral cancer. Medscape. https://emedicine.medscape.com/article/451496-overview
Hayes J, Gilligan T (2014) Nonurothelial bladder cancer. UpToDate. http://www.uptodate.com/contents/nonurothelial-bladder-cancer
Kaplan GW, Bulkey GJ, Grayhack JT (1967) Carcinoma of the male urethra. J Urol 98(3):365–371. [Medline]
National Comprehensive Cancer Network (2014) NCCN clinical practice guidelines in oncology (NCCN guidelines). Bladder Cancer (Version 2). http://www.tri-kobe.org/nccn/guideline/urological/english/bladder.pdf
National Institutes of Health (2014) Smoking and Bladder Cancer. http://www.nih.gov/researchmatters/august2011/08292011cancer.htm
Necchi A, Anichini A, Raggi D, Briganti A, Massa S, Luciano R (2018) Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study. J Clin Oncol 36(34):3353–3360
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655. Eastern Cooperative Oncology Group, Robert Comis M.D., Group Chair The ECOG Performance Status is in the public domain therefore available for public use
Patel A, Campbell S (2009) Current trends in the management of bladder cancer. J Wound Ostomy Continence Nurs 31(3):91–93
Porter MP, Kerrigan MC, Donato BM, Ramsey SD (2011) Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Urol Oncol 29(3):252–258
Riesz P, Lotz G, Páska C, Szendrôi A, Majoros A, Németh Z, Törzsök P, Szarvas T, Kovalszky I, Schaff Z, Romics I, Kiss A (2007) Detection of bladder cancer from the urine using fluorescence in situ hybridization technique. Pathol Oncol Res 13(3):187–194. Epub 2007 Oct 7
SEER Cancer Statistics Factsheets: Bladder Cancer (2020) SEER survival monograph: cancer survival among adults: US SEER program, 1988-2001, patient and tumor characteristics. SEER program. NIH Pub. No. 07-6215. National Cancer Institute, Bethesda. http://seer.cancer.gov/statfacts/html/urinb.html. Accessed 23 Jan 2020
Swartz MA, Porter MP, Lin DW, Weiss NS (2006) Incidence of primary urethral carcinoma in the United States. Urology 68(6):1164–1168
Thomas L, Steinberg R, Gerard Nepple K, O’Donnell MA (2019) Sequential intravesical gemcitabine and docetaxel in the treatment of BCG-naïve patients with non-muscle invasive bladder cancer. J Clin Oncol 37(7):469
Valerio M, Lhermitte B, Bauer J, Jichlinski P (2011) Metastatic primary adenocarcinoma of the bladder in a twenty-five years old woman. Rare Tumors 3(1):e9
West DA, Cummings JM, Longo WE, Virgo KS, Johnson FE, Parra RO (1999) Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology 53(2):292–297
Wiener JS, Liu ET, Walther PJ (1992) Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra. Cancer Res 52(18):5018–5023
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lizardi-Calvaresi, A., Mitchell, S., Derossett, J. (2020). Bladder and Urothelial Cancer. In: Quallich, S., Lajiness, M. (eds) The Nurse Practitioner in Urology. Springer, Cham. https://doi.org/10.1007/978-3-030-45267-4_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-45267-4_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-45266-7
Online ISBN: 978-3-030-45267-4
eBook Packages: MedicineMedicine (R0)